Skip to main content

ADVERTISEMENT

Aysha Khan, MD

Clinical Pathways GPS
12/13/2016
Richard G Stefanacci, DO, MGH, MBA, AGSF, CMD—Column Editor
Aysha Khan, MD
Nader Tavakoli, MD, CMD, FAAFP
Multiple sclerosis (MS) is a disabling condition that is managed medically through an ever growing list of pharmaceutical treatments. Clinical pathways that focus primarily on treatments for the disease overlook...
Multiple sclerosis (MS) is a disabling condition that is managed medically through an ever growing list of pharmaceutical treatments. Clinical pathways that focus primarily on treatments for the disease overlook...
...
12/13/2016
Journal of Clinical Pathways